OCGN
Ocugen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.86
+16.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 34.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -17.71x
- Price / sales
- 64.00x
- Price / cash flow
- -4.79x
Enterprise value
- Enterprise value
- $281.1M
- EV / sales
- 61.37x
- EV / EBITDA
- -4.01x
- EV / EBIT
- -4.08x
- Market cap
- $293.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026